A Single-Arm, Open-Label, Phase I Study of GK01 for Advanced Solid Tumor

NCT06954558 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: GK01 Injection

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]